Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $630M (100.0% shares, 0.0% debt)

Holdings (16)

AXSM AXSOME THERAPEUTICS INC 24.6%

Value $155M Shares 2,011,647 Est. Cost $45.81 Unrealized +30.5%

NUVL NUVALENT INC 13.2%

Value $83.06M Shares 2,788,981 Est. Cost $22.43 Unrealized +24.3%

— VERONA PHARMA PLC 11.9%

Value $75.14M Shares 2,875,526 Est. Cost $9.80 Unrealized —

ONC BEIGENE LTD 8.4%

Value $52.66M Shares 239,443 Est. Cost $198.98 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 6.3%

Value $40.01M Shares 1,369,623 Est. Cost $15.80 Unrealized +45.8%

NBIX NEUROCRINE BIOSCIENCES INC 5.4%

Value $33.8M Shares 283,000 Est. Cost $92.29 Unrealized +26.9%

COGT COGENT BIOSCIENCES INC 5.1%

Value $31.89M Shares 2,758,975 Est. Cost $9.18 Unrealized +35.0%

BCRX BIOCRYST PHARMACEUTICALS INC 4.6%

Value $29.19M Shares 2,543,107 Est. Cost $10.32 Unrealized +20.9%

— ASTRIA THERAPEUTICS INC 4.5%

Value $28.31M Shares 1,901,397 Est. Cost $11.99 Unrealized —

ARGX ARGENX SE 4.4%

Value $27.85M Shares 73,526 Est. Cost $266.01 Unrealized —

TERN TERNS PHARMACEUTICALS INC 3.3%

Value $20.77M Shares 2,040,000 Est. Cost $3.72 Unrealized +79.1%

ANNX ANNEXON INC 2.8%

Value $17.36M Shares 3,358,563 Est. Cost $4.53 Unrealized +21.2%

TRVI TREVI THERAPEUTICS INC 1.7%

Value $10.99M Shares 5,696,515 Est. Cost $3.04 Unrealized -35.3%

— DBV TECHNOLOGIES SA 1.7%

Value $10.81M Shares 7,064,964 Est. Cost $2.30 Unrealized —

TYRA TYRA BIOSCIENCES INC 1.7%

Value $10.77M Shares 1,416,998 Est. Cost $14.88 Unrealized -52.5%

— IMARA INC 0.4%

Value $2.582M Shares 631,333 Est. Cost $4.09 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,011,647	$155M	24.6%	$45.81	+30.5%	COM	05464T104
NUVL	NUVALENT INC	2,788,981	$83.06M	13.2%	$22.43	+24.3%	COM	670703107
—	VERONA PHARMA PLC	2,875,526	$75.14M	11.9%	$9.80	—	SPONSORED ADS	925050106
ONC	BEIGENE LTD	239,443	$52.66M	8.4%	$198.98	—	SPONSORED ADR	07725L102
VRDN	VIRIDIAN THERAPEUTICS INC	1,369,623	$40.01M	6.3%	$15.80	+45.8%	COM	92790C104
NBIX	NEUROCRINE BIOSCIENCES INC	283,000	$33.8M	5.4%	$92.29	+26.9%	COM	64125C109
COGT	COGENT BIOSCIENCES INC	2,758,975	$31.89M	5.1%	$9.18	+35.0%	COM	19240Q201
BCRX	BIOCRYST PHARMACEUTICALS INC	2,543,107	$29.19M	4.6%	$10.32	+20.9%	COM	09058V103
—	ASTRIA THERAPEUTICS INC	1,901,397	$28.31M	4.5%	$11.99	—	COM	04635X102
ARGX	ARGENX SE	73,526	$27.85M	4.4%	$266.01	—	SPONSORED ADR	04016X101
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$20.77M	3.3%	$3.72	+79.1%	COM	880881107
ANNX	ANNEXON INC	3,358,563	$17.36M	2.8%	$4.53	+21.2%	COM	03589W102
TRVI	TREVI THERAPEUTICS INC	5,696,515	$10.99M	1.7%	$3.04	-35.3%	COM	89532M101
—	DBV TECHNOLOGIES SA	7,064,964	$10.81M	1.7%	$2.30	—	SPONSORED ADR	23306J101
TYRA	TYRA BIOSCIENCES INC	1,416,998	$10.77M	1.7%	$14.88	-52.5%	COM	90240B106
—	IMARA INC	631,333	$2.582M	0.4%	$4.09	—	COM	45249V107